35Pharma is currently developing HS135, a multi-specific receptor ectodomain ligand trap designed to neutralize activins & GDFs, which according to the company are clinically validated drivers of cardiopulmonary and metabolic disease
Improvements in glycemic control were noted in both groups with increased vegetable intake
Diabetic ketoacidosis (DKA) presents with extreme thirst, frequent urination, nausea, abdominal pain, and fruity-smelling breath
With 500 million people worldwide with type 2 diabetes and 890 million obese, scientists are working on new treatments to improve overall health and well-being
Using L-glutamine supplements may help manage irritable bowel syndrome (IBS)
This article examines whether Rybelsus causes UTIs, explores the medication's established side effect profile, and provides guidance on recognising and managing urinary symptoms whilst taking this diabetes treatment